Maltseva, M.; Galipeau, Y.; McCluskie, P.; Castonguay, N.; Cooper, C.L.; Langlois, M.-A.
Systemic and Mucosal Antibody Responses to SARS-CoV-2 Variant-Specific Prime-and-Boost and Prime-and-Spike Vaccination: A Comparison of Intramuscular and Intranasal Bivalent Vaccine Administration in a Murine Model. Vaccines 2025, 13, 351.
https://doi.org/10.3390/vaccines13040351
AMA Style
Maltseva M, Galipeau Y, McCluskie P, Castonguay N, Cooper CL, Langlois M-A.
Systemic and Mucosal Antibody Responses to SARS-CoV-2 Variant-Specific Prime-and-Boost and Prime-and-Spike Vaccination: A Comparison of Intramuscular and Intranasal Bivalent Vaccine Administration in a Murine Model. Vaccines. 2025; 13(4):351.
https://doi.org/10.3390/vaccines13040351
Chicago/Turabian Style
Maltseva, Mariam, Yannick Galipeau, Pauline McCluskie, Nicolas Castonguay, Curtis L. Cooper, and Marc-André Langlois.
2025. "Systemic and Mucosal Antibody Responses to SARS-CoV-2 Variant-Specific Prime-and-Boost and Prime-and-Spike Vaccination: A Comparison of Intramuscular and Intranasal Bivalent Vaccine Administration in a Murine Model" Vaccines 13, no. 4: 351.
https://doi.org/10.3390/vaccines13040351
APA Style
Maltseva, M., Galipeau, Y., McCluskie, P., Castonguay, N., Cooper, C. L., & Langlois, M.-A.
(2025). Systemic and Mucosal Antibody Responses to SARS-CoV-2 Variant-Specific Prime-and-Boost and Prime-and-Spike Vaccination: A Comparison of Intramuscular and Intranasal Bivalent Vaccine Administration in a Murine Model. Vaccines, 13(4), 351.
https://doi.org/10.3390/vaccines13040351
